top of page
  • Writer's pictureMonica Giudice

For the series “a chat with the team”: Mark Jenkins, COO

Updated: Nov 29, 2021

After graduating from Royal Holloway College with a Computer Science and Mathematics degree, Mark worked in various development roles prior to starting his first software business in 1989. In 1998, this was sold to a FTSE 250 financial sector business.

Afterwards, Mark went on to start or co-found several further businesses in the telecommunications sector in which he still remains active today.

Alongside this, Mark has bought and sold several businesses and invested in others both as a corporate partner and as an Angel Investor. He remains on the board of many of those investments in non-executive capacity.

Mark Jenkins, Chief Operating Officer

Mark’s portfolio covers Artificial-Intelligence-based video analytics, web personalisation software, medical diagnostics, call centre services, the cyclic economy, and sports social media.

A member of the Institute of Directors for many years, Mark is also a qualified private pilot, rescue diver and a keen sportsman.

When did you get involved with Occuity? Why did you feel it was the right thing for you?

I brought together (and was one of) the syndicate of investors that provided the capital for the seed round for Occuity. I am a big fan of the technology and can see it has the potential to revolutionise how we screen and monitor chronic health conditions.

Since you still work in many other businesses, what makes Occuity so special?

There are not many businesses that can be thought to be truly disruptive. If we get the technology right (and we are proving this out) then Occuity can be one of those businesses and has a real chance of becoming a global brand.

How do you feel about the situation right now?

We seem to be in the right place at the right time for investors right now. The medtech sector is very active at the moment and our non-invasive technology plays well into the changing health care requirements in this post-Covid world. If contact with patients can be avoided then this is in everyone's interests and of course, our products are designed around this central tenet.

How do you think Occuity will grow from now on?

It’s exciting to be involved with the company and are forecasting that we will more than double the number of employees over the next twelve months. More than that however, the key inflexion points are when we bring our first product to market and complete the internal trials of the Indigo and this will really accelerate the company's growth when they come to fruition later this year.

To meet more of our team and find why they chose to work at Occuity click here.

Want to join the team? Check out our Careers website.

135 views0 comments


bottom of page